The purpose of this study is to see if adding Binimetinib in combination with FOLFOX is more effective treatment. You must be diagnosed with biliary tract cancer with a MAPK pathway gene mutation.
Contact phoneTera Williams | 517.364.2910
Principal investigatorDr. Gordan Srkalovic, MD, PhD